Home » Topics » Regulatory

Regulatory
RSS

Follow-up results of phase III study support long-term efficacy of mitoxantrone in MS

April 26, 1999

Avandia approved in Mexico, approval recommended in U.S.

April 23, 1999

Amoxil cleared for b.i.d. dosing in children

April 22, 1999

FDA grants priority review status to Alza' sNDA for Doxil in ovarian cancer

April 20, 1999

European Commission approves novel albumin-free treatment for hemophilia A

April 19, 1999

Furosemide prevents sound-induced seizures in rat model

April 19, 1999

FDA approves amprenavir, first new protease inhibitor in more than two years

April 19, 1999

Higher dose of Rebif approved in E.U. for multiple sclerosis

April 15, 1999

In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting

April 15, 1999

FDA approves Fragmin for DVT after hip replacement surgery

April 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...